18.18新台幣0.05(0.28%)
2022/08/11更新
績效 / 1月2.77%
3月10.38%
1年1%
晨星評等 - 1.現金4.86%
- 2.股票19.01%
- 3.債券0.10%
- 4.其他76.03%
- 1.美國75.72%
- 2.新興亞洲6.40%
- 3.歐洲不包含歐元區5.17%
- 4.日本3.33%
- 5.英國2.72%
- 1.UnitedHealth Group Inc8.52%
- 2.Eli Lilly and Co5.50%
- 3.Johnson & Johnson4.01%
- 4.Cigna Corp3.97%
- 5.Novo Nordisk A/S Class B3.96%
- 6.Elevance Health Inc3.82%
- 7.Regeneron Pharmaceuticals Inc3.79%
- 8.Thermo Fisher Scientific Inc3.69%
- 9.Abbott Laboratories3.69%
- 10.Danaher Corp3.63%
- 1.現金4.86%
- 2.股票19.01%
- 3.債券0.10%
- 4.其他76.03%
- 1.美國75.72%
- 2.新興亞洲6.40%
- 3.歐洲不包含歐元區5.17%
- 4.日本3.33%
- 5.英國2.72%
- 1.UnitedHealth Group Inc8.52%
- 2.Eli Lilly and Co5.50%
- 3.Johnson & Johnson4.01%
- 4.Cigna Corp3.97%
- 5.Novo Nordisk A/S Class B3.96%
- 6.Elevance Health Inc3.82%
- 7.Regeneron Pharmaceuticals Inc3.79%
- 8.Thermo Fisher Scientific Inc3.69%
- 9.Abbott Laboratories3.69%
- 10.Danaher Corp3.63%